Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective - Top-Institutions - MDSpire

Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective

  • By

  • Dong Wu

  • Qing Yu

  • Qixiang Wu

  • Xiaoying Wang

  • Haojie Wei

  • Fengli Li

  • Guangli Li

  • Xiaowu Wang

  • Xiaojuan Wang

  • June 16, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Kimmel Cancer Center
    Johns Hopkins Kimmel Cancer Center

    Baltimore, MD

    Key Differentiators

    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

  • #4

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Oncology

Original Source(s)

Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective

  • by Dong Wu, Qing Yu, Qixiang Wu, Xiaoying Wang, Haojie Wei, Fengli Li, Guangli Li, Xiaowu Wang, Xiaojuan Wang

  • June 16, 2026

Related Content

Case Report: KIF5B-ALK–rearranged renal cell carcinoma

Prognostic model for three-year postoperative local recurrence in cutaneous squamous cell carcinoma: a Chinese multicenter cohort study

Clinicopathologic features and integrated outcome analysis of pediatric and young adult salivary secretory carcinoma